WASHINGTON, DC - Energy and Commerce Committee Chairman Fred Upton (R-MI) and Senator Tom Coburn (R-OK) commended the Food and Drug Administration for meeting today’s deadline to issue draft guidance on abuse-deterrent prescription drugs.
Members
Chairman: Joe Pitts (PA)
Vice Chairman: Michael C. Burgess, M.D. (TX)
Ed Whitfield (KY)
John Shimkus (IL)
Mike Rogers (MI)
Tim Murphy (PA)
Marsha Blackburn (TN)
Phil Gingrey (GA)
Cathy McMorris Rodgers (WA)
Leonard Lance (NJ)
Bill Cassidy (LA)
Brett Guthrie (KY)
Morgan Griffith (VA)
Gus Bilirakis (FL)
Renee Ellmers (NC)
Joe Barton (TX)
Fred Upton (MI)
Ranking Member: Frank Pallone, Jr. (NJ)
John D. Dingell (MI)
Eliot L. Engel (NY)
Lois Capps (CA)
Jan Schakowsky (IL)
Jim Matheson (UT)
Gene Green (TX)
G.K. Butterfield (NC)
John Barrow (GA)
Donna M. Christensen (VI)
Kathy Castor (FL)
John Sarbanes (MD)
Henry A. Waxman (CA)
Obamacare is a seriously flawed law that makes health care coverage less affordable, costs taxpayers more than advertised and fails to deliver on most of its other grand promises. Because of the results of the presidential election and the Supreme Court's decision last summer, repealing it during the next two years is highly unlikely.
Drugs Like Oxycontin Currently Manufactured with Tamper Resistant Formulas – Law Enforcement, Health Care Officials, and Parents Concerned with the Prospect of Non-Tamper-Resistant Versions Hitting the Market, Making Powerful Prescription Drugs Easier to Crush and Abuse
Excerpt: During the past month, we have heard from a number of concerned citizens, including parents, law enforcement officials, health care providers, state and local officials, and our colleagues in Congress, about the impending release of the non-tamper-resistant versions of these opioids.
WASHINGTON, DC – Energy and Commerce Committee Chairman Fred Upton (R-MI) today took to the floor of the U.S. House of Representatives to speak in support of the Spending Reduction Act of 2012.